SANTILLI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 10.359
EU - Europa 6.767
AS - Asia 6.465
Continente sconosciuto - Info sul continente non disponibili 1.150
SA - Sud America 808
AF - Africa 93
OC - Oceania 4
Totale 25.646
Nazione #
US - Stati Uniti d'America 10.097
SG - Singapore 2.653
CN - Cina 1.694
RU - Federazione Russa 1.419
IT - Italia 979
IE - Irlanda 954
UA - Ucraina 788
TR - Turchia 702
SE - Svezia 698
BR - Brasile 655
VN - Vietnam 602
GB - Regno Unito 567
DE - Germania 412
FR - Francia 408
IN - India 266
FI - Finlandia 250
CA - Canada 121
HK - Hong Kong 119
BD - Bangladesh 118
MX - Messico 74
AR - Argentina 69
PL - Polonia 65
NL - Olanda 54
JP - Giappone 51
IQ - Iraq 42
ZA - Sudafrica 35
AT - Austria 34
ES - Italia 29
ID - Indonesia 29
KR - Corea 25
PK - Pakistan 23
CZ - Repubblica Ceca 19
BE - Belgio 18
EC - Ecuador 17
VE - Venezuela 17
MA - Marocco 16
CL - Cile 14
JM - Giamaica 14
SA - Arabia Saudita 14
AZ - Azerbaigian 13
LT - Lituania 12
UZ - Uzbekistan 12
EU - Europa 11
IR - Iran 11
AL - Albania 10
CO - Colombia 10
IL - Israele 10
AE - Emirati Arabi Uniti 9
JO - Giordania 9
PH - Filippine 9
CR - Costa Rica 8
DZ - Algeria 8
PY - Paraguay 8
RO - Romania 8
EG - Egitto 7
LB - Libano 7
PE - Perù 7
TT - Trinidad e Tobago 7
NG - Nigeria 6
NI - Nicaragua 6
OM - Oman 6
QA - Qatar 6
UY - Uruguay 6
CH - Svizzera 5
ET - Etiopia 5
KE - Kenya 5
MY - Malesia 5
SV - El Salvador 5
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
BZ - Belize 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GR - Grecia 4
HN - Honduras 4
HU - Ungheria 4
NP - Nepal 4
PS - Palestinian Territory 4
RS - Serbia 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
BG - Bulgaria 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
PA - Panama 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CU - Cuba 2
GT - Guatemala 2
KH - Cambogia 2
MD - Moldavia 2
AG - Antigua e Barbuda 1
Totale 24.490
Città #
Singapore 2.036
San Jose 1.216
Chandler 1.086
Jacksonville 959
Dublin 939
Ashburn 868
Dallas 532
Beijing 462
Council Bluffs 422
Princeton 383
Southend 370
Izmir 335
Los Angeles 312
Santa Clara 249
Nanjing 235
Ho Chi Minh City 206
Dearborn 205
The Dalles 192
Wilmington 186
New York 185
Cambridge 159
Ann Arbor 144
Hanoi 141
Altamura 135
Chieti 116
Hong Kong 107
Moscow 103
Munich 103
Nanchang 99
Tongling 99
Boardman 90
Buffalo 90
Pescara 79
São Paulo 69
Washington 69
Orem 63
Helsinki 61
Redondo Beach 57
Montreal 50
Brooklyn 49
Shenyang 49
Hebei 48
Kunming 47
Tokyo 46
Woodbridge 44
Tianjin 42
Rome 39
Warsaw 38
Denver 34
Milan 34
Turku 33
Chennai 32
Changsha 31
Jiaxing 31
Stockholm 31
Frankfurt am Main 30
Grevenbroich 30
Mexico City 30
Seattle 30
Chicago 29
Hefei 29
London 29
Norwalk 29
Phoenix 29
Atlanta 28
Poplar 28
Augusta 27
Columbus 27
Johannesburg 27
Toronto 27
Amsterdam 23
Seoul 23
Da Nang 22
Houston 22
Nuremberg 22
Manchester 20
San Francisco 20
Ankara 19
Boston 19
Hangzhou 19
Dong Ket 18
Jinan 18
Shanghai 18
Changchun 17
Lanzhou 17
Mumbai 17
San Mateo 17
Brussels 16
Belo Horizonte 15
Falls Church 15
Rio de Janeiro 15
Vienna 15
Baghdad 14
Brno 14
Guangzhou 14
Haiphong 14
Naples 14
Querétaro 14
St Louis 14
Baku 12
Totale 14.786
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 883
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 192
Pentraxin 3 and platelet activation in obese patients after gastric banding 181
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 177
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 175
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 172
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 170
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 169
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 168
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 165
Basophil Activation Test with Different Polyethylene Glycols in Patients with Suspected PEG Hypersensitivity Reactions 162
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 160
Oxidative-induced membrane damage in diabetes lymphocytes: effects on intracellular Ca2+ homeostasis 160
Role of growth factors in the development of diabetic complications 160
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 159
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 157
24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy 157
Determinants of platelet activation in hypertensives with microalbuminuria. 156
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 153
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 152
Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. 150
Association of low-grade inflammation and platelet activation in hypertensive patients with microalbuminuria 147
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 147
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 147
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 146
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 146
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 145
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 145
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 144
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 144
Neurocognitive impairment and suicide risk among prison inmates 144
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 142
Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis 142
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 142
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 141
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 141
Subcutaneous adipose tissue elastosonography in obese patients: a preliminary report 141
Platelets and Diabetes 140
Post-traumatic stress in pregnant women with primary cytomegalovirus infection and risk of congenital infection in newborns. 140
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 139
Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy. 138
Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy 138
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 138
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 137
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 137
COVID-19 and RAS: Unravelling an Unclear Relationship 137
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 136
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 135
A Complex Interaction between Rickettsia conorii and Dickkopf-1 - Potential Role in Immune Evasion Mechanisms in Endothelial Cells 134
Coagulation and infective endocarditis: sooner or later 134
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 134
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 134
Insulin resistance as a determinant of platelet activation in obese women. 133
Livelli circolanti di adiponectina e interleuchina-10 nell’obesità di tipo androide. 133
Platelets and diabetes mellitus 133
Platelet activation in obesity and metabolic syndrome. 132
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 132
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 132
Aspirin, platelets, and cancer: The point of view of the internist. 132
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 132
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 131
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 131
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 131
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 131
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: Effects of anti-TNFα treatment 130
The role of antileukotrienes in the treatment of asthma. 129
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 129
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 128
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis. 128
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 127
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. 127
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 127
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 127
Antiplatelet Agents. Thromboxane receptors antagonists and/or synthase inhibitors 126
Determinants of platelet activation in hypertensives with microalbuminuria. 125
Soluble forms of RAGE in internal medicine. 125
Extracellular vesicles number and cell subtype may be influenced by diabetes mellitus and metformin in patients at high cardiovascular risk 125
The role of nitric oxide in the development of diabetic angiopathy. 124
Soluble RAGE in type 2 diabetes: association with oxidative stress. 124
Association between PAI-1 and Oxidative Stress in Android Obesity 124
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 123
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 122
Homocysteine and education but not lipoprotein (a) predict estimated 10-year risk of cardiovascular disease in blood donors: a community based cross-sectional study 121
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 121
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 120
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 120
Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus 120
Increased Vascular Endothelial Growth Factor Serum Concentrations May Help to Identify Patients with Onset of Type 1 Diabetes during Childhood at risk for Developing Persistent Microalbuminuria 120
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 119
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 118
The deadly line linking sympathetic overdrive, dipping status and vascular risk: Critical appraisal and therapeutic implications 118
The left atrial appendage: from embryology to prevention of thromboembolism 118
Atherothrombotic disease and the metabolic syndrome. 117
I biomarcatori nella stratificazione del rischio. Cosa aggiungono nella gestione del paziente. 117
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 116
Real-Life Effectiveness of Subcutaneous Immune Therapy with Carbamylated Monomeric Allergoids on Mite, Grass, and Pellitory Respiratory Allergy: A Retrospective Study 115
Thromboxane-dependent CD40L release in type 2 diabetes mellitus 114
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 114
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients 114
Correlation between Migraine Severity and Cholesterol Levels 114
Totale 14.502
Categoria #
all - tutte 105.370
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.370


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022976 0 26 10 175 76 43 39 75 97 55 112 268
2022/20232.957 232 426 180 284 276 596 160 240 377 36 86 64
2023/20241.741 104 44 119 51 131 551 363 107 39 51 25 156
2024/20253.728 242 703 577 88 92 172 141 171 344 174 448 576
2025/20269.205 647 336 905 1.079 897 459 1.440 469 1.557 813 394 209
2026/2027552 192 360 0 0 0 0 0 0 0 0 0 0
Totale 25.646